Clinical Trial Update: Prevention of COVID-19 Infection to Severe Pneumonia or ARDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating prevention of progression from COVID-19 infection to severe pneumonia or ARDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Snippet

Sponsor: Enzychem Lifesciences Corporation | Conditions: Covid19 Pneumonia | Phase 2 | Status: UNKNOWN